Volume 98, Issue 2
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645



In countries where poliomyelitis has been eradicated, Guillain–Barré syndrome (GBS) is the leading cause of acute flaccid paralysis. The range of infections that precede GBS in Brazil is unknown. infection is the most frequent trigger of GBS worldwide. Given the lack of systematic surveillance of diarrheal diseases, particularly in adults, the incidence of enteritis caused by in developing countries is unknown. From 2014 to 2016, pretreatment serum samples from 63 GBS patients were tested by immunoglobulin M (IgM) enzyme-linked immunosorbent assay for . IgM antibodies were detected in 17% (11/63) of the samples. There was no association between serological positivity (IgM) for and the occurrence of diarrhea among the investigated cases ( = 0.36). Hygiene measures, basic sanitation, and precautions during handling and preparation of food of animal origin may help prevent acute flaccid paralysis.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...



  1. Centers for Disease Control and Prevention, 2013. Incidence and trends of infection with pathogens transmitted commonly through food—foodborne diseases active surveillance network, 10 U.S. sites, 1996–2012. MMWR Morb Mortal Wkly Rep 62: 283287. [Google Scholar]
  2. Young KT, Davis LM, Dirita VJ, , 2007. Campylobacter jejuni: molecular biology and pathogenesis. Nat Rev Microbiol 5: 665679. [Google Scholar]
  3. Blaser MJ, Berkowitz ID, LaForce FM, Cravens J, Reller LB, Wang WL, , 1979. Campylobacter enteritis: clinical and epidemiologic features. Ann Intern Med 91: 179185. [Google Scholar]
  4. Coker AO, Isokpehi RD, Thomas BN, Amisu KO, Obi CL, , 2002. Human campylobacteriosis in developing countries. Emerg Infect Dis 8: 237244. [Google Scholar]
  5. McCarthy N, Giesecke J, , 2001. Incidence of Guillain–Barre syndrome following infection with Campylobacter jejuni. Am J Epidemiol 153: 610614. [Google Scholar]
  6. van Doorn PA, Ruts L, Jacobs BC, , 2008. Clinical features, pathogenesis, and treatment of Guillain–Barre syndrome. Lancet Neurol 7: 939950. [Google Scholar]
  7. Guillain–Barre Syndrome Study Group, 2000. Guillain–Barre syndrome: an Italian multicentre case-control study. Neurol Sci 21: 229234. [Google Scholar]
  8. Hadden RD , 2001. Preceding infections, immune factors, and outcome in Guillain–Barre syndrome. Neurology 56: 758765. [Google Scholar]
  9. Jacobs BC, Rothbarth PH, van der Meche FG, Herbrink P, Schmitz PI, de Klerk MA, van Doorn PA, , 1998. The spectrum of antecedent infections in Guillain–Barre syndrome: a case-control study. Neurology 51: 11101115. [Google Scholar]
  10. Krauer F, Riesen M, Reveiz L, Oladapo OT, Martinez-Vega R, Porgo TV, Haefliger A, Broutet NJ, Low N, , 2017. Zika virus infection as a cause of congenital brain abnormalities and Guillain–Barre syndrome: systematic review. PLoS Med 14: e1002203. [Google Scholar]
  11. Vieira MA, Romano AP, Borba AS, Silva EV, Chiang JO, Eulalio KD, Azevedo RS, Rodrigues SG, Almeida-Neto WS, Vasconcelos PF, , 2015. West Nile virus encephalitis: the first human case recorded in Brazil. Am J Trop Med Hyg 93: 377379. [Google Scholar]
  12. McGrogan A, Madle GC, Seaman HE, de Vries CS, , 2009. The epidemiology of Guillain–Barre syndrome worldwide. A systematic literature review. Neuroepidemiology 32: 150163. [Google Scholar]
  13. Mishu B, Ilyas AA, Koski CL, Vriesendorp F, Cook SD, Mithen FA, Blaser MJ, , 1993. Serologic evidence of previous Campylobacter jejuni infection in patients with the Guillain–Barre syndrome. Ann Intern Med 118: 947953. [Google Scholar]
  14. Saida T, Kuroki S, Hao Q, Nishimura M, Nukina M, Obayashi H, , 1997. Campylobacter jejuni isolates from Japanese patients with Guillain–Barre syndrome. J Infect Dis 176 (Suppl 2): S129S134. [Google Scholar]
  15. Vriesendorp FJ, Mishu B, Blaser MJ, Koski CL, , 1993. Serum antibodies to GM1, GD1b, peripheral nerve myelin, and Campylobacter jejuni in patients with Guillain–Barre syndrome and controls: correlation and prognosis. Ann Neurol 34: 130135. [Google Scholar]
  16. Schmidt-Ott R, Schmidt J, Feldmann S, Brass F, Krone B, Gross U, , 2006. Improved serological diagnosis stresses the major role of Campylobacter jejuni in triggering Guillain–Barré syndrome. Clin Vaccine Immunol 13: 779783. [Google Scholar]
  17. da Silva Quetz J, Lima IF, Havt A, de Carvalho EB, Lima NL, Soares AM, Mota RM, Guerrant RL, Lima AA, , 2010. Campylobacter jejuni and Campylobacter coli in children from communities in northeastern Brazil: molecular detection and relation to nutritional status. Diagn Microbiol Infect Dis 67: 220227. [Google Scholar]
  18. Fernandez H, Toledo MR, Fagundes Neto U, Trabulsi LR, , 1985. Occurrence of Campylobacter jejuni in diarrhoeic and non-diarrhoeic children in Sao Paulo, Brazil. Rev Inst Med Trop São Paulo 27: 102104. [Google Scholar]
  19. Fernández H, , 2011. Campylobacter y campylobacteriosis: una mirada desde Amereica del Sur. Rev Peru Med Exp Salud Publica 28: 7. [Google Scholar]
  20. Walgaard C, Lingsma HF, Ruts L, van Doorn PA, Steyerberg EW, Jacobs BC, , 2011. Early recognition of poor prognosis in Guillain–Barre syndrome. Neurology 76: 968975. [Google Scholar]

Data & Media loading...

  • Received : 22 Aug 2017
  • Accepted : 25 Oct 2017
  • Published online : 08 Jan 2018

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error